As well as its needed effects, omeprazole may cause unwanted side effects that require medical attention. 
Some omeprazole side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:
The most commonly reported side effects included headache, abdominal pain, nausea, and diarrhea.
Lightheadedness occurred predominantly in severely ill or elderly patients.Taste disturbance usually resolved when treatment was stopped.Taste perversion most commonly occurred in patients given concomitant treatment with clarithromycin.
Very common (10% or more): Taste perversion (Up to 15%)Common (1% to 10%): Headache, drowsiness, somnolence, dizzinessUncommon (0.1% to 1%): Paresthesia, vertigo, taste disturbancesRare (0.01% to 0.1%): LightheadednessPostmarketing reports: Tremor
Very common (10% or more): Diarrhea (Up to 14%)Common (1% to 10%): Abdominal pain, constipation, flatulence, nausea/vomiting, acid regurgitation, tongue discolorationRare (0.01% to 0.1%): Dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitisVery rare (less than 0.01%): Dyspepsia, hemorrhagic necrotic gastritisPostmarketing reports: Pancreatitis (sometimes fatal), irritable colon, fecal discoloration, esophageal candidiasis, mucosal atrophy of the tongue, Clostridium difficile associated diarrhea, abdominal swelling, gastric fundic gland polyps
Hemorrhagic necrotic gastritis has been reported in pediatric patients.Diarrhea most commonly occurred in patients given concomitant treatment with clarithromycin and amoxicillin.Benign gastric fundic gland polyps were rarely reported, and appeared to be reversible when omeprazole was discontinued.
Common (1% to 10%): Upper respiratory infection, cough, rhinitis, pharyngitis/pharyngeal painRare (0.01% to 0.1%): BronchospasmVery rare (less than 0.01%): DyspneaFrequency not reported: Adverse reactions of the respiratory systemPostmarketing reports: Epistaxis
Patients 1 to less than 2 years of age had the highest frequency of adverse reactions of the respiratory system, followed by patients 1 month to less than 1 year and patients 2 to 16 years of age.
Otitis media occurred most frequently in patients 1 month to less than 1 year of age.Fever most commonly occurred in patients 1 to less than 2 years of age.Accidental injury most commonly occurred in patients 2 to 16 years of age.
Common (1% to 10%): Asthenia, flu-syndromeUncommon (0.1% to 1%): MalaiseRare (0.01% to 0.1%): FeverFrequency not reported: Otitis media, accidental injuryPostmarketing reports: Pain, fatigue, tinnitus
Common (1% to 10%): RashUncommon (0.1% to 1%): Dermatitis, alopecia, skin eruptions, erythema multiforme, urticaria and/or pruritusRare (0.01% to 0.1%): Photosensitivity, increased sweating/hyperhidrosis, Stevens-Johnson syndrome, toxic epidermal necrolysis (some fatal)Frequency not reported: Subacute cutaneous lupus erythematosusPostmarketing reports: Severe generalized skin reactions, skin inflammation, petechia
Common (1% to 10%): InsomniaRare (0.01% to 0.1%): Agitation, confusion/reversible mental confusion, depression, aggression, hallucinationsPostmarketing reports: Anxiety, apathy, nervousness, dream abnormalities, psychiatric and sleep disturbances
Confusion, agitation, aggression, depression, and hallucinations occurred predominantly in severely ill or elderly patients.
Common (1% to 10%): Back painUncommon (0.1% to 1%): Fracture of the hip/wrist/spineRare (0.01% to 0.1%): Arthralgia, myalgia, muscular weakness, joint painPostmarketing reports: Muscle cramps, leg pain, bone fracture
Uncommon (0.1% to 1%): Increased liver enzymes (ALT, AST, GGT, alkaline phosphatase, bilirubin)Rare (0.01% to 0.1%): Hepatitis with/without jaundice, hepatic failure/encephalopathyPostmarketing reports: Liver disease, fatal hepatic failure, liver necrosis (some fatal), hepatocellular disease, cholestatic disease, mixed hepatitis, jaundice
Hepatic encephalopathy occurred in patients with preexisting liver disease.
Peripheral edema usually resolved when treatment was stopped.
Uncommon (0.1% to 1%): Peripheral edemaPostmarketing reports: Chest pain/angina, tachycardia, bradycardia, palpitations, elevated blood pressure/hypertension
Rare (0.01% to 0.1%): Leukopenia, thrombocytopenia, agranulocytosis, pancytopeniaPostmarketing reports: Purpura, fatal agranulocytosis, hemolytic anemia, neutropenia, anemia, leukocytosis
Rare (0.01% to 0.1%): Hypersensitivity reactions, angioedema, anaphylactic reaction/shock, allergic vasculitis
Rare (0.01% to 0.1%): HyponatremiaVery rare (less than 0.01%): Weight increase, hypomagnesemia with/without hypocalcemia and/or hypokalemia, hypokalemiaFrequency not reported: HypocalcemiaPostmarketing reports: Anorexia, hypoglycemia
Severe hypomagnesemia may result in hypocalcemia, and may be associated with hypokalemia.Hypokalemia was reported in pediatric patients.
Irreversible visual impairment has been reported in critically ill patients who generally received high doses of the IV formulation as a bolus; however, no causal relationship has been established.
Rare (0.01% to 0.1%): Blurred visionFrequency not reported: Irreversible visual impairmentPostmarketing reports: Optic atrophy, anterior ischemic optic neuropathy, optic neuritis, dry eye syndrome, ocular irritation, double vision
Rare (0.01% to 0.1%): Interstitial nephritisVery rare (less than 0.01%): Impaired renal function, nephrosisPostmarketing reports: Elevated serum creatinine, glycosuria
A causal relationship between this drug and impotence has not been established.
Very rare (less than 0.01%): ImpotencePostmarketing reports: Hematuria, proteinuria, microscopic pyuria, urinary tract infection, urinary frequency, testicular pain
Very rare (less than 0.01%): Gynecomastia
Gastroduodenal carcinoids have been reported in patients with Zollinger-Ellison syndrome on long-term therapy.  This condition may be a manifestation of the underlying condition, which is known to cause tumors.
Postmarketing reports: Gastroduodenal carcinoids
It is possible that some side effects of omeprazole may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.
Back, leg, or stomach pain
bleeding or crusting sores on the lips
blisters
bloody or cloudy urine
chills
continuing ulcers or sores in the mouth
difficult, burning, or painful urination
fever
frequent urge to urinate
general feeling of discomfort or illness
joint pain
loss of appetite
muscle aches or cramps
pain
red or irritated eyes
redness, tenderness, itching, burning, or peeling of the skin
skin rash or itching
sore throat
sores, ulcers, or white spots on the lips, in the mouth, or on the genitals
unusual bleeding or bruising
unusual tiredness or weakness
Drowsiness
fast, racing, or uneven heartbeat
mood or mental changes
muscle spasms (tetany) or twitching seizures
nausea or vomiting
trembling
Blurred vision
confusion
dryness of the mouth
flushing
headache
increased sweating
Body aches or pain
chest pain
constipation
cough
diarrhea or loose stools
difficulty with breathing
dizziness
ear congestion
gas
heartburn
loss of voice
muscle pain
nasal congestion
runny nose
sneezing
unusual drowsiness